Manske Wealth Management’s GSK GSK Stock Holding History

Manske Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.98M	Sell	37,767 -802	-2%	-$42.4K	0.49%	43
2026 Q1	$2.13M	Sell	38,569 -434	-1%	-$23.5K	0.6%	38
2025 Q4	$1.91M	Sell	39,003 -1,462	-4%	-$68.2K	0.57%	37
2025 Q3	$1.75M	Sell	40,465 -286	-0.7%	-$11.2K	0.54%	40
2025 Q2	$1.56M	Buy	40,751 +1,563	+4%	+$59.7K	0.52%	43
2025 Q1	$1.52M	Buy	39,188 +1,028	+3%	+$37.6K	0.57%	38
2024 Q4	$1.29M	Buy	+38,160	New	+$1.37M	0.51%	41

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Manske Wealth Management's GSK Position: Q2 2026 in Review

Manske Wealth Management reduced its GSK (GSK) stake by 2.1% in Q2 2026, selling an estimated $42.4K and leaving 37,767 shares worth $1.98M. The position accounts for 0.49% of the portfolio, ranked #43.

Manske Wealth Management first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.13M in Q1 2026. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Manske Wealth Management held 37,767 shares of GSK worth $1.98M as of Q2 2026.
Manske Wealth Management sold 802 GSK shares in Q2 2026, an estimated $42.4K.
GSK made up 0.49% of Manske Wealth Management's portfolio in Q2 2026, its #43 holding.
Manske Wealth Management first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
Manske Wealth Management's GSK position peaked at $2.13M in Q1 2026.
1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Manske Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.